US HB3473 | 2013-2014 | 113th Congress
Status
Sponsorship: Partisan Bill (Democrat 7)
Status: Introduced on November 13 2013 - 25% progression, died in committee
Action: 2013-11-13 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 13 2013 - 25% progression, died in committee
Action: 2013-11-13 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to make permanent the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics). Extends the $1 billion allocation for such credit for each 2-year period beginning after 2013 and provides for a biennial inflation adjustment to such allocation amount after 2015.
Title
Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2013
Sponsors
| Rep. Susan Davis [D-CA] | Rep. Andre Carson [D-IN] | Rep. Gerald Connolly [D-VA] | Rep. Ron Kind [D-WI] |
| Rep. Scott Peters [D-CA] | Rep. Allyson Schwartz [D-PA] | Rep. Juan Vargas [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2013-11-13 | House | Referred to the House Committee on Ways and Means. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/house-bill/3473/all-info |
| Text | https://www.congress.gov/113/bills/hr3473/BILLS-113hr3473ih.pdf |
